AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11095450
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human growth hormone (rhGH) at a mean dose of 6.7 microg/kg x day (1.6 IU/day)
Trial: 8036599
Drug: Prospidin (total
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prospidin (total dose 3.0‐9.8 g)
Trial: 27425565
Drug: Strong Minds
RxNorm normalized name: monofluorophosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strong Minds program (acceptance and commitment therapy combined with positive psychology)
Trial: 3068300
Drug: Cisapride (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride (10 mg q.i.d.)
Trial: 23955106
Drug: d-chlorpheniramine 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-chlorpheniramine 4 mg
Trial: 21422197
Drug: Placebo administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administration in women with hypothalamic amenorrhea
Trial: 2842144
Drug: Flumazenil (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil (0.2 mg)
Trial: 17275695
Drug: Sublingual nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual nitroglycerin administration (0.6 mg)
Trial: 11488317
Drug: 200 microg
RxNorm normalized name: Digoxin 200 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 microg inhaled salbutamol
Trial: 11514686
Drug: 800 microg
RxNorm normalized name: Fentanyl 800 microgram buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 microg inhaled salbutamol
Trial: 7512124
Drug: Growth factors
RxNorm normalized name: INVEST HEMATOLOGIC DEFICIENCIES,HEMATOPOEITIC GROWTH FACTORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth factors (GFs) including G-CSF (7.5 micrograms/kg/d) and GM-CSF (2.5 micrograms/kg/d) administered as a 2-hour intravenous infusion twice per day until neutrophil count > 1,500/microL
Trial: 3948703
Drug: Indoramin (0.2‐0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indoramin (0.2‐0.4 mg/kg bodyweight)
Trial: 20196974
Drug: 6.6 g
RxNorm normalized name: FERROUS SULFATE 76.6 g in 454 g TOPICAL POWDER [Hemostat]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.6 g marine n‐3 PUFA/day
Trial: 20196974
Drug: 2.0 g
RxNorm normalized name: Fifty50 2.0 Glucose Meter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 g marine n‐3 PUFA/day
Trial: 20196974
Drug: 6.6 g
RxNorm normalized name: FERROUS SULFATE 76.6 g in 454 g TOPICAL POWDER [Hemostat]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.6 g olive oil (control)
Trial: 15179022
Drug: Venlafaxine XR
RxNorm normalized name: venlafaxine Extended Release Oral Capsule
DrugBank: Venlafaxine (DB00285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Venlafaxine XR (75-150 mg)
Trial: 9302488
Drug: Creatine (Cr)
DrugBank: Creatine (DB00148)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Creatine (Cr) supplementation (5 g creatine plus 1 g glucose X 5 doses daily for 7 days)
Trial: 9302488
Drug: Placebo (Pl)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (Pl) treatment (6 g glucose X 5 doses daily for 7 days)
Trial: 9302488
Drug: Placebo (Pl)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (Pl) treatment
Trial: 8171738
Drug: IL-2 subcutaneous
RxNorm normalized name: Ile
DrugBank: Isoleucine (DB00167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IL-2 subcutaneous therapy (3 million IU twice/daily for 5 days/week for 6 weeks)
Trial: 8171738
Drug: IL-2 subcutaneous
RxNorm normalized name: Ile
DrugBank: Isoleucine (DB00167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IL-2 subcutaneous therapy
Trial: 31177888
Drug: 24-h urine
RxNorm normalized name: Urin DS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-h urine protein excretion
Trial: 16420567
Drug: Standard dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dosage of rFVIIa (90 microg kg(‐1), repeated every 3 h)
Trial: 16420567
Drug: High dosage
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dosage of rFVIIa (270 microg kg(‐1), single dose)
Trial: 1789830
Drug: Intravenous rehydration
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous rehydration therapy
Trial: 31268011
Drug: Oral rehydration
RxNorm normalized name: Oral rehydration salt formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral rehydration therapy
Trial: 29695208
Drug: Antagonist protocol
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Antagonist protocol (group C)
Trial: 22349668
Drug: Vitamin D(3)
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D(3) oral drops
Trial: 22349668
Drug: Placebo oral
RxNorm normalized name: placebo ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo oral drops
Trial: 19703572
Drug: Xenon (glutamate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xenon (glutamate receptor antagonist)
Trial: 16151341
Drug: 16-channel sequential
RxNorm normalized name: CHANNEL CATFISH
DrugBank: Channel catfish (DB15548)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16-channel sequential stimulation with 2500 pps per channel
Trial: 16151341
Drug: 8-channel sequential
RxNorm normalized name: CHANNEL CATFISH
DrugBank: Channel catfish (DB15548)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-channel sequential stimulation with 5000 pps per channel
Trial: 8533058
Drug: New antiepileptic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New antiepileptic drugs (vigabatrin, lamotrigine, gabapentin, oxcarbazepine, felbamate)
Trial: 902005
Drug: Tablet identification
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet identification card
Trial: 30845333
Drug: Vi-polysaccharide conjugate
RxNorm normalized name: Typhoid Vi polysaccharide vaccine
DrugBank: Typhoid Vi polysaccharide vaccine (DB10803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vi-polysaccharide conjugate vaccine (Vi-TCV)
Trial: 23593139
Drug: Electroacupuncture at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture at acupoint (treatment group)
Trial: 21768545
Drug: Insulin-sensitizing strategy
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin-sensitizing strategy
Trial: 20110037
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of bicalutamide 50-mg tablets
Trial: 11718031
Drug: Mifepristone 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone 5 mg (Group A)
Trial: 11718031
Drug: Mifepristone 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone 10 mg (Group B)
Trial: 2574626
Drug: Terfenadine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine (60 mg) twice daily
Trial: 31143019
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment of chronic sinusitis
Trial: 24623024
Drug: Intensive insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive insulin therapy (IT)
Trial: 12882067
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of metoclopramide
Trial: 7734367
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg cladribine/m2/d
Trial: 7398190
Drug: Diphenhydramine 50
RxNorm normalized name: diphenhydrAMINE 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine 50 mg/70 kg body weight (intravenously or orally)
Trial: 6342648
Drug: Topical PUVA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical PUVA with 2-h interval therapy (1% 8-methoxypsoralen followed by UV-A exposure 2 hours later)
Trial: 6342648
Drug: Topical PUVA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical PUVA with non-interval therapy (1% 8-methoxypsoralen followed by UV-A exposure within 5 minutes)
Trial: 30630792
Drug: Intradermal injection
RxNorm normalized name: Dryvax Intradermal Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal injection of tranexamic acid and glutathione
Trial: 7859936
Drug: Low-dose bedtime
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose bedtime insulin alone
Trial: 25873064
Drug: everolimus (trough
FDA approved: no
EMA approved: no
PMDA approved: no
Description: everolimus (trough levels 3-8 ng/mL) with reduced tacrolimus (trough levels <5 ng/mL)
Trial: 25873064
Drug: standard tacrolimus
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: standard tacrolimus (trough levels 6-10 ng/mL)
Trial: 10409125
Drug: DCA (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DCA (100 mg/kg body mass)
Trial: 24384646
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogen-based hormone therapy (HT)
Trial: 22648840
Drug: Early oral
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early oral feeding with enteral nutrition preparation
Trial: 20395537
Drug: Darifenacin ER
RxNorm normalized name: Darifenacin ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darifenacin ER 7.5 mg
Trial: 20395537
Drug: Darifenacin ER
RxNorm normalized name: Darifenacin ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darifenacin ER 15 mg
Trial: 20140437
Drug: Tolterodine 4
RxNorm normalized name: tolterodine 4 mg oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine 4 mg
Trial: 18713926
Drug: Ketamine 1
RxNorm normalized name: ketamine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 1 mg/kg followed by 83 microg x kg(‐1) x h(‐1) (ketamine-2 group)
Trial: 12391068
Drug: Acetazolamide (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetazolamide (500 mg twice daily for 5 doses)
Trial: 1642024
Drug: Piroxicam (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam (0.3 mg/kg)
Trial: 21959480
Drug: Diclofenac (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (1 mg/kg)
Trial: 12161042
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg isoflavones (Promensil)
Trial: 10519337
Drug: Lignocaine-prilocaine cream
RxNorm normalized name: lidocaine / prilocaine Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine-prilocaine cream (EMLA)
Trial: 8443031
Drug: Digoxin tablets
RxNorm normalized name: Digoxin Tablets
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Digoxin tablets (250 micrograms)
Trial: 8443031
Drug: Liquid filled
RxNorm normalized name: Senna Oral Capsule, Liquid Filled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid filled digoxin capsules (100 micrograms)
Trial: 8443031
Drug: Experimental enteric-coated
RxNorm normalized name: lipase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental enteric-coated capsule (100 micrograms)
Trial: 6766049
Drug: Intravenous control
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous control
Trial: 2428462
Drug: Alternating regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternating regimen (same drugs alternating in monthly cycles with doxorubicin, dacarbazine, and bleomycin)
Trial: 23318149
Drug: Intranasal H1N1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal H1N1 vaccine
Trial: 2895483
Drug: Remoxipride 150‐600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remoxipride 150‐600 mg/day
Trial: 25539805
Drug: Alternative-mechanism TNF-inhibitor
RxNorm normalized name: Tumor necrosis factor alpha (TNF-alpha) inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternative-mechanism TNF-inhibitor (TNFi) or abatacept
Trial: 18707799
Drug: Topical methyl-aminolevulinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical methyl-aminolevulinate (MAL) cream applied under occlusion for 3 hours, followed by illumination with red light-emitting diode (630 nm, light dose 37 J/cm2)
Trial: 18707799
Drug: Vehicle cream
RxNorm normalized name: vehicle cream base no.160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle cream applied under occlusion for 3 hours, followed by illumination with red light-emitting diode (630 nm, light dose 37 J/cm2)
Trial: 2717521
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg oral ketorolac tromethamine (KT)
Trial: 2717521
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg intramuscular ketorolac tromethamine (KT)
Trial: 25933031
Drug: Alendronate 70
RxNorm normalized name: ALENDRONATE 70MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 70 mg weekly
Trial: 19075192
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Alendronate and Indapamide
Trial: 15179024
Drug: Acamprosate 2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acamprosate 2000 mg/day
Trial: 11216976
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral loading dose of propafenone (600 mg)
Trial: 2271372
Drug: Cholestyramine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholestyramine (8 g)
Trial: 510196
Drug: 10 tablets
RxNorm normalized name: ALLANTOIN 0.11 in 600 mg VAGINAL TABLET [Jilgyungyi (10 Tablets)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 tablets of 800 mg bacampicillin (t.i.d.)
Trial: 510196
Drug: 20 tablets
RxNorm normalized name: ALLANTOIN 0.11 in 600 mg VAGINAL TABLET [Jilgyungyi (20 Tablets)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 tablets of 800 mg bacampicillin (t.i.d.)
Trial: 510196
Drug: 30 tablets
RxNorm normalized name: nitrogen 30 %
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 tablets of 800 mg bacampicillin (t.i.d.)
Trial: 16033749
Drug: Topical tetracycline
RxNorm normalized name: TETRACYCLINE HYDROCHLORIDE 30 mg in 1 mL TOPICAL SPRAY [Tetracyte Topical Tetracycline Hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical tetracycline
Trial: 16033749
Drug: Single-dose azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Single-dose azithromycin for the surgical patient
Trial: 16033749
Drug: Single-dose azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Single-dose azithromycin for the surgical patient and all household members
Trial: 28007331
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (rosuvastatin 5 mg/ezetimibe 10 mg, rosuvastatin 10 mg/ezetimibe 10 mg, rosuvastatin 20 mg/ezetimibe 10 mg)
Trial: 28007331
Drug: Monotherapy (rosuvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy (rosuvastatin 5 mg, rosuvastatin 10 mg, rosuvastatin 20 mg)
Trial: 25997043
Drug: Purified anthocyanin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified anthocyanin (320 mg/d)
Trial: 19802534
Drug: Shenshao Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenshao Tablet (SST)
Trial: 15297779
Drug: Pantoprazole 20
RxNorm normalized name: pantoprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole 20 mg once daily in the morning
Trial: 9258989
Drug: Cotinine fumarate
RxNorm normalized name: Chinine
DrugBank: Quinine (DB00468)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cotinine fumarate (40, 80, or 160 mg)
Trial: 23312808
Drug: Supportive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive treatment only
Trial: 28703421
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) with supportive treatment
Trial: 22327873
Drug: Intravenous vancomycin
RxNorm normalized name: Vancomycin
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous vancomycin
Trial: 9699761
Drug: Intravenous cefazolin
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous cefazolin
Trial: 22699036
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg nitroglycerin
Trial: 22699036
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg nitroglycerin
Trial: 22699036
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg lidocaine + 30 mg nitroglycerin
Trial: 22699036
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg lidocaine + 30 mg nitroglycerin
Trial: 19320851
Drug: Ciclesonide (CIC)
RxNorm normalized name: Ciclesonide
DrugBank: Ciclesonide (DB01410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciclesonide (CIC) 320 μg
Trial: 18339441
Drug: Achievers (maintained
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Achievers (maintained glucose levels below 8mmol/L)
Trial: 8562293
Drug: Litoxetine (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Litoxetine (twice daily for 4 days)
Trial: 6988006
Drug: Antenatal corticosteroid
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antenatal corticosteroid treatment (betamethasone)
Trial: 31823552
Drug: Extracorporeal shock
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal shock wave therapy (Group B)
Trial: 31823552
Drug: Extracorporeal shock
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal shock wave therapy combined with autologous PRP injection (Group C)
Trial: 20003205
Drug: Intra-articular hyaluronic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular hyaluronic acid (Hyalubrix) injections
Trial: 12875478
Drug: Lacidipine 4
RxNorm normalized name: lacidipine 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacidipine 4 mg o.d.
Trial: 3319646
Drug: Chlorthalidone 12.5
RxNorm normalized name: chlorthalidone 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone 12.5 mg o.d.
Trial: 12875478
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (Lacidipine and Chlorthalidone)
Trial: 10383520
Drug: LTdbCA (lansoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LTdbCA (lansoprazole 30 mg b.d., tri-potassium dicitrato bismuthate one tablet b.d., clarithromycin 250 mg b.d., amoxycillin 1 g b.d. for 3 days)
Trial: 10383520
Drug: RbcCA (ranitidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RbcCA (ranitidine bismuth citrate 400 mg b.d., clarithromycin 250 mg b.d., amoxycillin 1 g b.d. for 3 days)
Trial: 10383520
Drug: OCM (omeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OCM (omeprazole 20 mg b.d., clarithromycin 250 mg b.d., metronidazole 400 mg b.d. for 1 week)
Trial: 6342133
Drug: Debrisoquin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Debrisoquin (20 mg/day)
Trial: 6342133
Drug: Methyldopa (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methyldopa (100 mg/day)
Trial: 2481787
Drug: Propranolol (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (160 mg/day)
Trial: 30497202
Drug: Classic surgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Classic surgical and rehabilitative treatments
Trial: 12084664
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of 35% CO(2)
Trial: 31437853
Drug: Room air
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Room air inhalation
Trial: 9708611
Drug: L-carnitine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine supplementation (1 g administered orally before and after hemodialysis treatments)
Trial: 7609274
Drug: No-Iron (total
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-Iron (total parenteral nutrition without iron)
Trial: 2227819
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (13 to 15 mg/kg/day) for 5 weeks
Trial: 660211
Drug: Once or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once or twice a day dosage regimens of phenytoin
Trial: 30942029
Drug: Auricular gold-needle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auricular gold-needle therapy
Trial: 6562990
Drug: Intravaginal application
RxNorm normalized name: taurolidine
DrugBank: Taurolidine (DB12473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravaginal application of oestriol tablets (1 to 3 mg daily for 1 or more cycles)
Trial: 31500690
Drug: Maintenance supplements
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance supplements of 1,000 IU/day for those with normal serum 25(OH)D levels
Trial: 3140587
Drug: Bromocriptine 5
RxNorm normalized name: bromocriptine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine 5 mg daily for 4 cycles